Ligand · SR7
SR7 · N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide
SR7, N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide (C25 H23 N7 O S, 469.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- SR7
- Formula
- C25 H23 N7 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
SR7 in 2 structures; the first of them:
- 4BN5 · Structure of human SIRT3 in complex with SRT1720 inhibitor · SR7 A1396 · binds ILE154, PRO155, ASP156, PHE157, ARG158, LEU164, GLU177, PHE180 and 9 more
- 4BN5 · Structure of human SIRT3 in complex with SRT1720 inhibitor · SR7 A1396 · binds ILE154, PRO155, ASP156, PHE157, ARG158, LEU164, GLU177, PHE180 and 9 more
Residues it binds most
PHE 24, LEU 24, ILE 24, VAL 24, PRO 24, ARG 24, HIS 24, ASP 22, GLU 14, GLY 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.